Assay system for the assessment of oncogenicity, tumor progression, and treatment efficacy

Details for Australian Patent Application No. 2009206289 (hide)

Owner Cytotech Labs, LLC

Inventors Persaud, Indushekhar; Narain, Niven Rajin

Agent Spruson & Ferguson

Pub. Number AU-A-2009206289

PCT Pub. Number WO2009/094619

Priority 61/023,570 25.01.08 US

Filing date 26 January 2009

Wipo publication date 30 July 2009

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/094619 Priority application(s): WO2009/094619

30 June 2011 Assignment before Grant

  Cytotech Labs, LLC The application has been assigned to Berg Biosystems, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009206293-Method for discriminating between malignant and benign tissue lesions

2009206283-Acetic acid/thymol compositions and their use in the treatment of onychomycosis